Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher John Kenney currently holds 7,069 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher John Kenney has been a net seller of XENE stock. They have purchased $20.2K and sold $268.9K worth of shares.
Christopher John Kenney's most recent insider trade was on Mar 13, 2026, when they sold 1,410 shares at $55.23 per share.
Christopher John Kenney serves as Executive at Xenon Pharmaceuticals Inc. (XENE). They have executed 10 insider transactions totaling $289.1K over their tenure at the company.
Christopher John Kenney holds the position of Executive at Xenon Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Christopher John Kenney has shown a selling trading pattern, with $20.2K in total purchases and $268.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher John Kenney was on Mar 10, 2026, when they sold $166.6K worth of XENE shares. This transaction involved 2,771 shares at $60.11 per share.
Christopher John Kenney currently owns 7,069 shares of Xenon Pharmaceuticals Inc. (XENE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher John Kenney's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher John Kenney has 10 Form 4 filings on record as an insider at Xenon Pharmaceuticals Inc..
Set alerts for Christopher John Kenney and 40,000+ other insiders.